SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-19-000082
Filing Date
2019-10-29
Accepted
2019-10-29 16:53:58
Documents
7
Period of Report
2019-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-form8xkwarrantagreeme.htm 8-K 45228
2 EXHIBIT 4.1 sesn-2017warrantexerciseag.htm EX-4.1 33286
3 EXHIBIT 4.2 sesn-2017warrantamendmenta.htm EX-4.2 39400
4 EXHIBIT 4.3 sesn-2018warrantexerciseag.htm EX-4.3 33561
5 EXHIBIT 4.4 sesn-2018warrantamendmenta.htm EX-4.4 39391
6 EXHIBIT 10.1 sesn-spaamendment.htm EX-10.1 23679
7 EXHIBIT 99.1 sesn-warrantspressrelease_.htm EX-99.1 10615
  Complete submission text file 0001485003-19-000082.txt   226491
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 191176414
SIC: 2834 Pharmaceutical Preparations